Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride improves heart function in obese and aging male rats by reducing oxidative stress and p53 protein levels.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Dutasteride is more effective than finasteride at increasing hair count and reversing hair thinning in men with hair loss, but both have similar side effects.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Dutasteride reduces DHT more effectively than finasteride.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Tamsulosin increases the risk of floppy iris during eye surgery.

Stinging nettle has compounds that help with joint pain, arthritis, and prostate issues.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Glioblastoma cells can make androgens, which might help the tumor grow.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.